Hypoglycaemic activity of saponin fraction extracted from momordica charantia in PEG/salt aqueous two-phase systems

Natural Product Research

Volumn 22, Issue 13, 2008, Pages 1112-1119

  Han, Chuncho ^a   Hui, Qiusha ^a   Wang, Yingzi ^b  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Blood glucose; Glycogen; Insulin; Momordica charantia; Saponin constituents; Sugar tolerance

Indexed keywords

ALLOXAN; GLUCOSE; GLYCOGEN; INSULIN; MACROGOL; MOMORDICA CHARANTIA EXTRACT; SAPONIN; SODIUM CHLORIDE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG ISOLATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN SYNTHESIS; HYPERGLYCEMIA; HYPOGLYCEMIC ACTIVITY; INSULIN BLOOD LEVEL; INSULIN RELEASE; MOMORDICA CHARANTIA; MOUSE; NONHUMAN;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MOMORDICA CHARANTIA; PLANT EXTRACTS; POLYETHYLENE GLYCOLS; SALTS; SAPONINS;

CUCUMIS; CUCURBITACEAE; MOMORDICA CHARANTIA; MUS;

EID: 54249160922     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410802079675     Document Type: Article

References (22)

1. Murakami, T., Emoto, A., Matsuda, H. and Yoshikawa, M. (2001) Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull. (Tokyo), 49, pp. 54-63.
2. Guevara, AP, Lim-Sylianco, C., Dayrit, F. and Finch, P. (1990) Antimutagens from Momordica charantia. Mutat. Res., 230, pp. 121-126.
3. Jilka, C., Strifler, B., Fortner, GW, Hays, EF and Takemoto, DJ (1983) In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Res., 43, pp. 5151-5155.
4. Ng, TB, Chan, WY and Yeung, HW (1992) Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceal plants. Gen. Pharmacol., 23, pp. 579-590.
5. Karunanayake, EH and Tennekoon, KH (1993) Search of novel hypoglycaemic agents from medicinal plants. Diabetes Mellitus and its Complications, an Update, pp. 192-205. Macmillan, New Delhi, India
6. Platel, K. and Srinivasan, K. (1997) Plants foods in the management of diabetes mellitus: Vegetables as potential hypoglycemic agents. Nahrung, 41, pp. 68-74.
7. Jaspreet, V. (2003) Antihyperglycemic effects of three extracts from Momordica charantia L. J. Ethnopharmacol., 88, pp. 107-111.
8. Oishi, Y., Sakamoto, T. and Udagawa, H. (2007) Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci. Biotech. Biochem., 71, pp. 735-740.
9. Harinantenaina, L., Tanaka, M., Takaoka, S., Oda, M., Mogami, O. Uchida, M. et al. (2006) Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem. Pharma. Bull., 54, pp. 1017-1021.
10. Kimura, Y., Akihisa, T. and Yuasa, N. (2005) Cucurbitane-type triterpenoids from the fruit of Momordica charantia. J. Nat. Prod., 68, pp. 807-809.
11. Eiteman, MA and Gainer, JL (1990) Peptide hydrophobicity and partitioning in poly(ethylene glycol)/magnesium sulfate aqueous two-phase systems. Biotechnol. Prog., 6, pp. 479-484.
12. Walter, H., Brooks, DE and Fisher, D. (1985) Partitioning in Aqueous Two-phase Systems: Theory, Methods, Uses, and Applications to Biotechnology, Academic Press, Orlando, FL
13. Li, C., Ouyang, F. and Bai, J. (2000) Extractive cultivation of Lactococcus lactis using a poly(ethylene glycol)/MgSO4-7H2O aqueous two-phase systems to produce nisin. Biotechnol. Lett., 22, pp. 843-847.
14. Pan, IH, Chiu, HH and Lu, CH (2002) Aqueous two-phase extraction as an effective tool for isolation of geniposide from gardenia fruit. J. Chromatogr. A, 22, pp. 239-246.
15. You, Y. and Lin, Z. (2003) Antioxidant effect of Ganoderma polysaccharide peptide. Acta Pharmacol. Sin., 38, pp. 85-88.
16. Anderson, L., Dinesen, B., Jorgenson, P., Poulsen, F. and Roder, M. (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin. Chem., 8, p. 578.
17. Keppler, D. and Decker, K. (1974) Glycogen. Methods of Enzymatic Analysis, pp. 11-17. Academic Press, New York
18. Duncan, DB (1957) Multiple range tests for correlated and heteroscedastic means. Biometrics, 13, pp. 164-176.
19. Grover, JK, Yadav, S. and Vats, V. (2002) Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol., 81:1, pp. 81-100.
20. Shibib, BA, Khan, LA and Rahman, R. (1993) Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1, 6-biphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem. J., 292, pp. 267-270.
21. Leatherdale, BA, Pansar, RK, Singh, G., Atkins, TW, Bailey, CJ and Bignell, AHC (1981) Improvement in glucose tolerance due to Momordica charantia (Karela). Brit. Med. J., 282, pp. 1823-1824.
22. Oishi, Y., Sakamoto, T., Udagawa, H., Taniguchi, H. and Kobayashi-Hattori, K. (2007) Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci. Biotech. Biochem., 71:3, pp. 735-740.